medrogestone sold brand name colprone among others progestin medication used menopausal hormone therapy treatment gynecological available alone combination taken medrogestone progestin synthetic progestogen hence agonist progesterone receptor biological target progestogens like weak antiandrogenic glucocorticoid antimineralocorticoid activity important hormonal due progestogenic activity medrogestone antigonadotropic medrogestone described early introduced medical use least mostly discontinued remains available past medrogestone used treatment endometrial cancer regimens breast cancer men benign prostatic hyperplasia still finds use treatment progestin component certain forms menopausal hormone cyclic treatment lowdose mgday medrogestone found effective treatment fibrocystic breast changes associated mastodynia breast medrogestone used form progestogenonly birth control although specifically licensed intrahepatic cholestasis pregnancy acute history vaginal bleeding unknown origin severe diseases liver tumors absolute contraindications medrogestone thrombotic events thrombophlebitis medrogestone contraindicated pregnancy progestogens associated risks fetus animals known whether medrogestone passes breast milk expected given lipophilicity studies structurally related medrogestone seldom produces side effects typical progestogens include nausea acute toxicity drug low overdose causes harmless side effects nausea vaginal found range mgkg dogs mgkg rats chronic toxicity examined animals nothing typical adverse effects progestogens reduction prostatic weight rhesus monkeys found accidental intake drug including children normally dangerous intake extremely large doses intake patients epilepsy impaired kidney function result central nervous enzyme inducers barbiturates phenylbutazone phenytoin ampicillin tetracyclines expected reduce plasma concentrations medrogestone systematic research medrogestone described pure progestogen similar profile contrast progesterone however medrogestone potent orally reportedly information available receptor binding medrogestone various steroid hormone however based animal research eg clauberg test assays medrogestone appears potent progestogen devoid androgenic estrogenic glucocorticoid activity weak antiandrogenic weak antimineralocorticoid accordingly evidence androgenic glucocorticoid activity including effects estrogeninduced increase triglycerides hdl cholesterol adrenal suppression observed clinical however highdosage mgday months study medrogestone benign prostatic hyperplasia hyperglycemic effect changes plasma cortisol levels observed considered likely secondary glucocorticoid activity decreased sodium levels also observed attributed antimineralocorticoid case normal circumstances ie typical clinical dosages medrogestone described progestogen antigonadotropin weak antiandrogen humans without clinically relevant medrogestone found inhibitor isomerase vitro preventing conversion pregnenolone progesterone rat testis preparations inhibits biosynthesis testosterone vivo addition similarly progesterone medrogestone inhibit vitro microsomal preparations skin although clinical relevance uncertain actions medrogestone could contribute weak antiandrogen upon oral administration medrogestone rapidly absorbed bioavailability nearly ingestion mg dose medrogestone peak circulating concentrations cmax ngml distribution elimination halflives medrogestone hours hours drug largely bound albumin small extents corticosteroidbinding globulin sex hormonebinding globulin metabolism medrogestone importantly medrogestone also known synthetic pregnane steroid derivative progesterone structurally related derivatives megestrol acetate medroxyprogesterone medrogestone derivative instead derivative features methyl group position instead hydroxy acetoxy addition methyl group medrogestone possesses methyl group position double bond structural difference medrogestone megestrol acetate replacement acetoxy group methyl oral activity already alluded compound may well owe property inhibition metabolism manner analogous synthetic androgens estrogens sufficiently potent right constitute useful drug incorporation known potentiating modifications yields commercially available oral progestin medrogestone preparation acetate precursor covered reduction conjugated double bond acetate means lithium liquid ammonia leads initially enolate ion alkylated situ methyl iodide nowfamiliar steric control asserts afford compound acetate group lost side reaction interesting modification usual scheme treated aluminum isopropoxide ketone oppenauer conditions well chloranil single reaction medrogesterone obtained directly step medrogestone first described early appears marketed since least medrogestone generic name drug inntooltip international nonproprietary name usantooltip united states adopted name bantooltip british approved also known developmental code names medrogestone marketed brand names ayerluton colpro colpron colprone etogyn prothil combination conjugated estrogens medrogestone marketed united canada widely throughout europe well argentina hong kong however longer available united many countries reported remain marketed countries including france germany tunisia httpsenwikipediaorgwikimedrogestone